Wild-type (senile) amyloidosis secondary prevention
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]
Overview
Overview
There are no established measures for the secondary prevention of wild-type (senile) amyloidosis.
Secondary Prevention
Secondary Prevention
There are no established measures for the secondary prevention of wild-type (senile) amyloidosis.
References
References
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH